S 155355, A novel benzodioxopiperazine ligand of serotonin (5-HT)1(A) receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 1, 1997, Pages 148-161

  Millan, Mark J ^a,f   Hjorth, Stephan ^c   Samanin, Rosario ^d   Schreiber, Rudy ^a,e   Jaffard, Robert ^b   De Ladonchamps, Brigitte ^a   Veiga, Sylvie ^a   Goument, Bertrand ^a   Peglion, Jean Louis ^a   Spedding, Michael ^a   Brocco, Mauricette ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e MEDA Manufacturing GmbH   (Germany)

^f INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1,4 BENZODIOXAN 5 YL) 4 (2 INDANYL)PIPERAZINE; AMPHETAMINE; ANXIOLYTIC AGENT; AUTORECEPTOR; BUSPIRONE; DIAZEPAM; HALOPERIDOL; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PENBUTOLOL; SEROTONIN; SEROTONIN 1A RECEPTOR; TERTATOLOL; UNCLASSIFIED DRUG; 4 (BENZODIOXAN 5 YL) 1 (INDAN 2 YL)PIPERAZINE; 4-(BENZODIOXAN-5-YL)-1-(INDAN-2-YL)PIPERAZINE; PIPERAZINE DERIVATIVE; SEROTONIN 1 RECEPTOR; SEROTONIN AGONIST; SEROTONIN RECEPTOR;

AGGRESSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFLICT; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; FEAR; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MAZE TEST; NEUROTRANSMISSION; NONHUMAN; ORAL DRUG ADMINISTRATION; PIGEON; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION; TRANQUILIZING ACTIVITY; ANIMAL; DRUG EFFECT; FEMALE; INSTITUTE FOR CANCER RESEARCH MOUSE; MOTOR ACTIVITY; MOUSE; PIGEONS AND DOVES; SECRETION; SPRAGUE DAWLEY RAT; VOCALIZATION; WISTAR RAT;

AGGRESSION; ANIMALS; ANTI-ANXIETY AGENTS; BUSPIRONE; COLUMBIDAE; FEMALE; HIPPOCAMPUS; MALE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; VOCALIZATION, ANIMAL;

EID: 0030610730     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. 1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. Eur. J. Pharmacol. 264: 259-264, 1994.
2. BARBEE, J. G., BLACK, F. W., KEHOE, C. E. AND TODOROV, A. A.: A comparison of the single-dose effects of alprazolam, buspirone and placebo upon memory function. J. Clin. Pharmacol. 11: 351-356, 1991.
3. 3 Antagonists and Benzodiazepines: Their Comparative Behavioural Pharmacology, ed. by R. J. Rogers and S. J. Cooper, pp. 59-105, Wiley & Sons Ltd, Chichester, 1991.
4. 1A receptor antagonists (+)WAY100135 and WAY100635. Neuropharmacology 34: 805-811, 1995.
5. 1A antagonist (-)-alprenolol fails to modify sleep or zimeldine-induced sleep-waking effects in rats. Pharmacol. Biochem. Behav. 42: 49-56, 1992.
6. 1A agonists buspirone and gepirone. Pharmacol. Biochem. Behav. 31: 279-286, 1988.
7. BROCCO, M. J., KOEK, W., DEGRYSE, A.-D. AND COLPAERT, F. C.: Comparative studies on the anti-punishment effects of chlordiazepoxide, buspirone and ritanserin in the pigeon, Geller-Seifter and Vogel conflict procedures. Behav. Pharmacol. 1: 403-418, 1990.
8. BRUNO, F.: Buspirone in the treatment of alcoholic patients. Psychopathology 22: 49-59, 1989.
9. 1A receptors in the hippocampus. Behav. Brain Res. 67: 67-74, 1995a.
10. 1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine. Eur. J. Pharmacol. 283: 133-139, 1995b.
11. 1A receptors causes amnesia and anxiolytic-like but not antidepressant-like effects in the rat. Eur. J. Pharmacol. 234: 215-221, 1993.
12. CASES, O., SEIF, I., GRIMSBY, J., GASPAR, P., CHEN, K., POURNIN, S., MÜLLER, U., AGUET, M., BABINET, C., CHEN SHIH, J. AND DE MAEYER, E.: Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 268: 1763-1766, 1995.
13. 1A receptors mediate the effect of ipsapirone on punished responding in rats. Eur. J. Pharmacol. 284: 249-255, 1995a.
14. 3) receptor antagonists increase rates of punished responding in rats. Pharmacol. Biochem. Behav. 4: 671-676, 1995b.
15. CHARNEY, D. S. AND REDMOND, D. E.: Neurobiological mechanisms in human anxiety. Evidence supporting central noradrenergic hyperactivity. Neuropharmacology 22: 1531-1536, 1983.
16. COLLINS, D. M. AND MYERS, R. D.: Buspirone attenuates volitional alcohol intake in the chronically drinking monkey. Alcohol 4: 49-56, 1987.
17. COPLAN, J. D., GOKMAN, J. M. AND KLEIN, D. F.: Serotonin related functions in panic-anxiety: a critical overview. Neuropsychopharmacology 6: 189-200, 1992.
18. 1A receptor. In Psychopharmacology: The Fourth Generation in Progress, ed. by F. E. Bloom and D. J. Kupfer, pp.1301-1310, Raven Press, Ltd, New York, 1995.
19. DAWSON, G. R. AND TRICKLEBANK, M. D.: Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol. Sci. 16: 32-36, 1995.
20. DEAKIN, J. F. W.: Three distinct roles of 5-HT in anxiety, panic, and depression. In Psychopharmacology of Depression, ed. by S. A. Montgomery and T. H. Corn, British Association for Psychopharmacology Monograph, 13: 87-101, 1994.
21. 1A agonists in anxiety and depression. J. Psychopharmacol. 7: 283-289, 1993.
22. 1A receptor agonists: Recent developments and controversial issues. Psychopharmacology 121: 1-26, 1995.
23. DE VRY, J., BENZ, U., SCHREIBER, R. AND TRABER, J.: Shock-induced vocalization in young adults rats: a model for testing putative anti-anxiety drugs. Eur. J. Pharmacol. 249: 331-339, 1994.
24. 1A receptor binding in the human brain postmortem: Effects of age and alcohol. Brain Res. 554: 56-64, 1991.
25. EVANS, S. M., TROISI, J. R. AND GRIFFITHS, R. R.: Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans. J. Pharmacol. Exp. Ther. 271: 683-694, 1994.
26. 1A agonists in drug-naive and in benzodiazepine-experienced rats. Behav. Pharmacol. 5: 99-102, 1994.
27. 1A receptor antagonist. Behav. Brain Res. 73: 337-353, 1996.
28. GAMMANS, R. E., STRINOFELLOW, J. C., HVIZDOS, A. J., SEIDEHAMEL, R. J., COHN, J. B., WILCOX, C. S., FABRE, L. F., PECKNOLD, J. C., SMITH, W. T. AND RICKELS, K.: Use of buspirone in patients with generalized anxiety disorder and coexisting depressive symptoms. Neuropsychobiology 25: 193-201, 1992.
29. 1A agonist, in normal volunteers. Psychopharmacology 166: 433-436, 1994.
30. 1A receptor agonists and antagonists: A comparison to adrenergic and dopaminergic neurons in rats. J. Pharmacol. Exp. Ther. 273: 1032-1046, 1995.
31. 1A agonist anxiolytic gepirone on benzodiazepine withdrawal signs in rats. Behav. Pharmacol. 2: 461-469, 1991.
32. GRADY, T. A., PIGOTT, T. A., L'HEUREUX, F., HILL, J. L., BERNSTEIN, S. E. AND MURPHY, D. L.: Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder. Am. J. Psychiatry 150: 819-821, 1993.
33. HANDLEY, S. L., MCBLANE, J. W., CRITCHLEY, M. A. E. AND NJUNG'E, K.: Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors. Behav. Brain Res. 58: 203-210, 1993.
34. 1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)-penbutolol. J. Pharmacol. Exp. Ther. 265: 707-712, 1993.
35. 1-adrenoceptors in the inhibition of 5-HT release. I. BMY 7378 and prazosin. Neuropharmacology 34: 615-620, 1995.
36. HODGES, H., GREEN, S. AND GLENN, B.: Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination. Psychopharmacology 92: 491-504, 1987.
37. 1c) receptors on periaqueductal gray aversion. Eur. J. Pharmacol. 161: 219-221, 1989.
38. 1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat? J. Pharmacol. Exp. Ther 272: 920-929, 1995.
39. 3 Antagonists and Benzodiazepines: Their Comparative Behavioural Pharmacology, ed. R. J. Rodgers and S. J. Cooper, pp. 343-363, Wiley & Son Ltd, Chichester, 1991
40. 1A autoreceptors enhances dopamine (DA) and noradrenaline (NAD) release in rat frontal cortex: Influence of S 15535, WAY 100,635 and 8-OH-DPAT. Eur. Neuropsychopharmacol. 6: S4.121-S4.122, 1996.
41. 1A receptor responsivity in anxiety disorders and depression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 15: 723-733, 1991.
42. 1A receptor responsivity in obsessive-compulsive disorder. Comparison of patients and controls. Arch. Gen. Psychiatry 48: 540-547, 1991.
43. LISTA, A., BLIER, P. AND DE MONTIGNY, C.: Benzodiazepine receptors modulate 5-hydroxytryptamine neurotransmission in the rat hippocampus: In vivo electrophysiological evidence. J. Pharmacol. Exp. Ther. 254: 318-323, 1990.
44. 3 Antagonists and Benzodiazepines: Their Comparative Behavioural Pharmacology, ed. R. J. Rodgers and S. J. Cooper, pp. 267-280, Wiley & Son Ltd, Chichester, 1991.
45. 2A receptors. Eur. J. Pharmacol. 280: R9-R11, 1995.
46. MENDELSON, W. B., MARTIN, J. V. AND RAPOPORT, D. M.: Effects of buspirone on sleep and respiration. Am. Rev. Respir. Dis. 141: 1527-1530, 1990.
47. A and 5-HT anxiolytics. Psychopharmacology 121: 38-56, 1995.
48. 1c/2 antagonists as therapeutic agents. Drug News Perspect. 5: 397-406, 1992a.
49. 1c/2 receptors. J. Pharmacol. Exp. Ther. 262: 451-463, 1992b.
50. 1c/2 antagonists as potential anxiolytic agents. In Anxiety: Neurobiology, Clinic and Therapeutic Perspectives, ed. by M. Hamon, H. Ollat, M.-H. Thiébot, pp. 153-165, J. Libbey Eurotext Ltd, London, 1993.
51. 1A antagonists. J. Pharmacol Exp. Ther. 268: 337-352, 1994.
52. MOELLER, F. G., DOUGHERTY, D. M., SWANN, A. C., COLLINS, D., DAVIS, C. M. AND CHEREK, D. R.: Tryptophan depletion and aggressive responding in healthy males. Psychopharmacology 126: 97-103, 1996.
53. MOLEWIJK, H. E., VAN DER POEL, A. M., Mos, J., VAN DER HEYDEN, J. A. M. AND OLIVIER, B.: Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs. Psychopharmacology 117: 32-40, 1995.
54. Mos, J. AND OLIVIER, B.: Quantitative and comparative analyses of proaggressive actions of benzodiazepines in maternal aggression of rats. Psychopharmacology 97: 152-153, 1989.
55. Mos, J., OLIVIER, B., POTH, M., VAN OORSCHOT, R. AND VAN AKEN, H.: The effects of dorsal raphe administration of eltoprazine, TFMPP and 8-OH-DPAT on resident intruder aggression in the rat. Eur. J. Pharmacol. 238: 411-415, 1993.
56. PAN, Z. Z. AND WILLIAMS, J. T.: GABA-and glutamate-mediated synaptic potentials in rat dorsal raphe neurons in vitro. J. Neurophysiol. 61: 719-726, 1989.
57. PATO, M. T., PIGOTT, T. A., HILL, J. L., GROVER, G. N., BERNSTEIN, S. AND MURPHY, D. L.: Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder. Am. J. Psychiatry 148: 127-129, 1991.
58. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, 2nd ed., Academic Press, Australia, 1986.
59. 1A compounds 8-hydroxy-2-(di-n-propylamino) tetralin and ipsapirone in the social interaction paradigm: evidence of a presynaptic action. Brain Res. Bull. 37: 169-175, 1995.
60. RATEY, J., SOVNER, R., PARKS, A. AND ROGENTINE, K.: Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study. J. Clin. Psychiatry 52: 159-162, 1991.
61. 1A receptor antagonist, in the murine elevated plus-maze test. Eur. J. Pharmacol. 261: 321-325, 1994.
62. SÁNCHEZ, C.: Effect of serotonergic drugs on footshock-induced ultrasonic vocalization in adult male rats. Behav. Pharmacol. 4: 269-277, 1993.
63. 1A receptors. Eur. J. Pharmacol. 264: 241-247, 1994.
64. SANFORD, L: D., Ross, R. J., SEGGOS, A. E., MORRISON, A. R., BALL, W. A. AND MANN, G. L.: Central administration of two 5-HT receptor agonists: effect on REM sleep initiation and PGO waves. Pharmacol. Biochem. Behav. 49: 93-100, 1994.
65. SCHEFKE, D. M., FONTANA, D. J. AND COMMISSARIS, R. L.: Anti-conflict efficacy of buspirone following acute versus chronic treatment. Psychopharmacology 99: 427-429, 1989.
66. 1A receptors. Psychopharmacology 112: 100-110, 1993.
67. 1A receptor ligands in animal models of anxiety, impulsivity and depression: multiple mechanisms of actions? Prog. Neuro-Psychopharmacol. Biol. Psychiatry 17: 87-104, 1993a.
68. 1A receptor agonists 8-OH-DPAT, ipsapirone and buspirone in the rat. Eur. J. Pharmacol. 249: 341-351, 1993b.
69. 1A receptors in the anxiolytic action of S 14671 in the pigeon conflict test. Pharmacol. Biochem. Behav. 51: 211-215, 1995a.
70. 1A receptor agonist, 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT). J. Pharmacol. Exp. Ther. 275: 822-831, 1995b.
71. SELLERS, E. M., HIGGINS, G. A. AND SOBELL, M. B.: 5-HT and alcohol abuse. Trends Pharmacol. Sci. 13: 69-75, 1992.
72. 1 receptors and offensive aggression in rats: A combined behavioural and autoradiographic study with eltoprazine, Pharmacol. Biochem. Behav. 38: 447-458, 1991.
73. STECKLER, T. AND SAHGAL, A.: The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour. Behav. Brain Res. 67: 165-199, 1995.
74. THIÉBOT, M.-H., SOUBRIÉ, P. AND SANGER, D.: Anxiogenic properties of beta-CCE and FG 7142: A review of promises and pitfalls. Psychophannacology 94: 452-463, 1988.
75. 1A agonist, on sleep/wakefulness cycles: probable postsynaptic action. J. Sleep Res. 2: 103-109, 1993.
76. TRICKLEBANK, M. D.: The behavioural response to 5-HT receptor agonists and subtypes of the central 5-HT receptor. Trends Pharmacol. Sci. 5: 403-407, 1985.
77. TYE, N. C., IVERSEN, S. D. AND GREEN, A. R.: The effects of benzodiazepines and serotonergic manipulations on punished responding. Neuropharmacology 18: 689-695, 1979.
78. VAN WIJNGAARDEN, I., TULP, M. TH. M. AND SOUDIJN, W.: The concept of selectivity in 5-HT receptor research. Eur. J. Pharmacol. 188: 301-312, 1990.
79. WHITE, S. M., KUCHARIK, R. F. AND MOYER, J. A.: Effects of serotonergic agents on isolation-induced aggression. Pharmacol. Biochem. Behav. 39: 729-736, 1991.
80. YUDOFSKY, S. C., SILVER, J. M. AND HALES, R. E.: Pharmacologic management of aggression in the elderly. J. Clin. Psychiatry 51: 22-28, 1990.